Landiolol is a rapid-acting beta-blocker used for rapid ventricular rate control.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceritinib | Landiolol may increase the bradycardic activities of Ceritinib. |
| Ivabradine | Landiolol may increase the bradycardic activities of Ivabradine. |
| Ruxolitinib | Ruxolitinib may increase the bradycardic activities of Landiolol. |
| Alfuzosin | Alfuzosin may increase the hypotensive activities of Landiolol. |
| Amifostine | Landiolol may increase the hypotensive activities of Amifostine. |
| Diazoxide | Diazoxide may increase the hypotensive activities of Landiolol. |
| Methylphenidate | Methylphenidate may decrease the antihypertensive activities of Landiolol. |
| Dexmethylphenidate | Dexmethylphenidate may decrease the antihypertensive activities of Landiolol. |
| Obinutuzumab | Landiolol may increase the hypotensive activities of Obinutuzumab. |
| Pentoxifylline | Pentoxifylline may increase the hypotensive activities of Landiolol. |
| Rituximab | Landiolol may increase the hypotensive activities of Rituximab. |
| Desmopressin | Desmopressin may decrease the antihypertensive activities of Landiolol. |
| Zolmitriptan | Zolmitriptan may decrease the antihypertensive activities of Landiolol. |
| Doxapram | Doxapram may decrease the antihypertensive activities of Landiolol. |
| Sumatriptan | Sumatriptan may decrease the antihypertensive activities of Landiolol. |
| Phenmetrazine | Phenmetrazine may decrease the antihypertensive activities of Landiolol. |
| Naratriptan | Naratriptan may decrease the antihypertensive activities of Landiolol. |
| Rizatriptan | Rizatriptan may decrease the antihypertensive activities of Landiolol. |
| Dopamine | Dopamine may decrease the antihypertensive activities of Landiolol. |
| Frovatriptan | Frovatriptan may decrease the antihypertensive activities of Landiolol. |
| Dutasteride | Dutasteride may decrease the antihypertensive activities of Landiolol. |
| Finasteride | Finasteride may decrease the antihypertensive activities of Landiolol. |
| Solifenacin | Solifenacin may decrease the antihypertensive activities of Landiolol. |
| Epicaptopril | Epicaptopril may decrease the antihypertensive activities of Landiolol. |
| 1-benzylimidazole | 1-benzylimidazole may decrease the antihypertensive activities of Landiolol. |
| Amineptine | Amineptine may decrease the antihypertensive activities of Landiolol. |
| Flibanserin | Flibanserin may decrease the antihypertensive activities of Landiolol. |
| Naluzotan | Naluzotan may decrease the antihypertensive activities of Landiolol. |
| Nitrous oxide | Nitrous oxide may decrease the antihypertensive activities of Landiolol. |
| Cinitapride | Cinitapride may decrease the antihypertensive activities of Landiolol. |
| Lurasidone | Lurasidone may decrease the antihypertensive activities of Landiolol. |
| Tyramine | Tyramine may decrease the antihypertensive activities of Landiolol. |
| Ifenprodil | Ifenprodil may decrease the antihypertensive activities of Landiolol. |
| Dimetacrine | Dimetacrine may decrease the antihypertensive activities of Landiolol. |
| Butriptyline | Butriptyline may decrease the antihypertensive activities of Landiolol. |
| Moxisylyte | Moxisylyte may decrease the antihypertensive activities of Landiolol. |
| Tianeptine | Tianeptine may decrease the antihypertensive activities of Landiolol. |
| Oxaprotiline | Oxaprotiline may decrease the antihypertensive activities of Landiolol. |
| Atipamezole | Atipamezole may decrease the antihypertensive activities of Landiolol. |
| Tetrahydrocannabivarin | Tetrahydrocannabivarin may decrease the antihypertensive activities of Landiolol. |
| Piclozotan | Piclozotan may decrease the antihypertensive activities of Landiolol. |
| Siponimod | Siponimod may decrease the antihypertensive activities of Landiolol. |
| Idazoxan | Idazoxan may decrease the antihypertensive activities of Landiolol. |
| Tramazoline | Tramazoline may decrease the antihypertensive activities of Landiolol. |
| Amitriptylinoxide | Amitriptylinoxide may decrease the antihypertensive activities of Landiolol. |
| Dibenzepin | Dibenzepin may decrease the antihypertensive activities of Landiolol. |
| Quinupramine | Quinupramine may decrease the antihypertensive activities of Landiolol. |
| Trichloroethylene | Trichloroethylene may decrease the antihypertensive activities of Landiolol. |
| Fenozolone | Fenozolone may decrease the antihypertensive activities of Landiolol. |
| Melitracen | Melitracen may decrease the antihypertensive activities of Landiolol. |
| Lofepramine | Lofepramine may decrease the antihypertensive activities of Landiolol. |
| Xenon | Xenon may decrease the antihypertensive activities of Landiolol. |
| Iprindole | Iprindole may decrease the antihypertensive activities of Landiolol. |
| Buflomedil | Buflomedil may decrease the antihypertensive activities of Landiolol. |
| Diethyl ether | Diethyl ether may decrease the antihypertensive activities of Landiolol. |
| Imipramine oxide | Imipramine oxide may decrease the antihypertensive activities of Landiolol. |
| Mefenorex | Mefenorex may decrease the antihypertensive activities of Landiolol. |
| 5-methoxy-N,N-dimethyltryptamine | 5-methoxy-N,N-dimethyltryptamine may decrease the antihypertensive activities of Landiolol. |
| Quinoline Yellow WS | Quinoline Yellow WS may decrease the antihypertensive activities of Landiolol. |
| Solriamfetol | Solriamfetol may decrease the antihypertensive activities of Landiolol. |
| Sufentanil | Sufentanil may decrease the antihypertensive activities of Landiolol. |
| Isoflurane | Isoflurane may decrease the antihypertensive activities of Landiolol. |
| Propofol | Propofol may decrease the antihypertensive activities of Landiolol. |
| Remifentanil | Remifentanil may decrease the antihypertensive activities of Landiolol. |
| Halothane | Halothane may decrease the antihypertensive activities of Landiolol. |
| Desflurane | Desflurane may decrease the antihypertensive activities of Landiolol. |
| Sevoflurane | Sevoflurane may decrease the antihypertensive activities of Landiolol. |
| Protriptyline | Protriptyline may decrease the antihypertensive activities of Landiolol. |
| Opipramol | Opipramol may decrease the antihypertensive activities of Landiolol. |
| Selpercatinib | Selpercatinib may decrease the antihypertensive activities of Landiolol. |
| Naxitamab | Naxitamab may decrease the antihypertensive activities of Landiolol. |
| Cannabidiol | The metabolism of Landiolol can be decreased when combined with Cannabidiol. |
| Amiodarone | The therapeutic efficacy of Landiolol can be increased when used in combination with Amiodarone. |
| Bupivacaine | The serum concentration of Bupivacaine can be increased when it is combined with Landiolol. |
| Dipyridamole | Dipyridamole may increase the bradycardic activities of Landiolol. |
| Disopyramide | Disopyramide may increase the bradycardic activities of Landiolol. |
| Dronedarone | Dronedarone may increase the bradycardic activities of Landiolol. |
| Fingolimod | Landiolol may increase the bradycardic activities of Fingolimod. |
| Floctafenine | The risk or severity of adverse effects can be increased when Landiolol is combined with Floctafenine. |
| Mepivacaine | The serum concentration of Mepivacaine can be increased when it is combined with Landiolol. |
| Methacholine | Landiolol may increase the bronchoconstrictory activities of Methacholine. |
| Midodrine | The therapeutic efficacy of Midodrine can be decreased when used in combination with Landiolol. |
| Nifedipine | The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Landiolol. |
| Propafenone | The risk or severity of adverse effects can be increased when Propafenone is combined with Landiolol. |
| Regorafenib | Regorafenib may increase the bradycardic activities of Landiolol. |
| Reserpine | Reserpine may increase the hypotensive activities of Landiolol. |
| Deserpidine | Deserpidine may increase the hypotensive activities of Landiolol. |
| Guanethidine | Guanethidine may increase the hypotensive activities of Landiolol. |
| Rivastigmine | Landiolol may increase the bradycardic activities of Rivastigmine. |
| Mirabegron | The serum concentration of Landiolol can be increased when it is combined with Mirabegron. |
| Molsidomine | Molsidomine may increase the hypotensive activities of Landiolol. |
| Insulin human | Landiolol may increase the hypoglycemic activities of Insulin human. |
| Insulin lispro | Landiolol may increase the hypoglycemic activities of Insulin lispro. |
| Insulin glargine | Landiolol may increase the hypoglycemic activities of Insulin glargine. |
| Insulin pork | Landiolol may increase the hypoglycemic activities of Insulin pork. |
| Insulin aspart | Landiolol may increase the hypoglycemic activities of Insulin aspart. |
| Insulin detemir | Landiolol may increase the hypoglycemic activities of Insulin detemir. |
| Insulin glulisine | Landiolol may increase the hypoglycemic activities of Insulin glulisine. |
| NN344 | Landiolol may increase the hypoglycemic activities of NN344. |
| Insulin beef | Landiolol may increase the hypoglycemic activities of Insulin beef. |